Medindia » Health Watch

Telogen Effluvium: Understanding Hair Loss as a Sequela of COVID-19

by Dr. Trupti Shirole on June 3, 2023 at 6:31 AM

Highlights:

Telogen effluvium (TE) is observed as a manifestation of COVID-19, leading to diffuse hair loss in infected individuals
The study found that a significant percentage of COVID-19-recovered patients experienced hair loss, with varying timelines of onset
Recognizing COVID-19 as a potential cause of hair loss can aid in patient education and understanding the transient nature of the condition

The COVID-19 pandemic has brought forth numerous challenges, both in terms of public health and the impact on individuals' overall well-being. While the primary focus has been on the respiratory symptoms and complications associated with the virus, emerging evidence suggests that COVID-19 may have additional effects on various parts of the body, including the hair (1^✔). This study aims to shed light on the presence of hair loss as a potential sequela of COVID-19 infection, specifically focusing on the second wave of the pandemic.

Hair Loss and COVID-19

Hair, often considered a cosmetic feature, has gained attention due to its medical significance. The human scalp comprises millions of follicles, and the hair growth cycle consists of three phases: anagen (growth), catagen (transition), and telogen (resting). Telogen effluvium (TE) is a condition characterized by sudden and excessive shedding of normal club hairs, typically occurring 2-3 months after a triggering event. Common causes include febrile illness, postpartum changes, surgery, emotional stress, and systemic illnesses. However, in some cases, no specific trigger can be identified.

Since the emergence of the novel coronavirus, medical professionals have observed various dermatological manifestations of COVID-19, including new-onset diffuse hair loss. This hair loss pattern aligns clinically with telogen effluvium and has raised concerns among researchers. With this background in mind, the present study aims to establish a link between hair loss and COVID-19 infection, focusing on the second wave of the pandemic.

Assessing Hair Loss in COVID-19 Patients

A cross-sectional study was conducted at a tertiary care center in South India. Using Google Forms, a questionnaire was designed to collect relevant data from COVID-19-positive patients who had recovered from the infection during the second wave. The questionnaire included questions about COVID-19 infection, the presence of hair loss, and factors that aggravated or relieved the condition. A total of 114 participants were included in the study, and their responses were collected and analyzed.

Hair Loss as a Post-COVID-19 Symptom

Among the 114 participants, the majority were female, reflecting a higher prevalence of hair loss concerns in women. Notably, 72% of the patients reported hair loss after recovering from COVID-19. Among those experiencing hair loss, 66.7% noticed a worsening of the condition after 3 weeks of COVID-19 infection, while 21.7% observed it within 2-3 weeks, and the remaining 11.7% noticed it within a week of infection. Additionally, 50.1% of the patients reported associated stress, while 12.3% had comorbidities.

COVID-19: A Potential Trigger for Hair Loss

The onset of telogen effluvium after COVID-19 infection further impacts the quality of life for patients, even after recovering from the primary illness. Recognizing COVID-19 as a potential trigger for hair loss is crucial in educating patients about the temporary nature of the condition. By understanding the connection between COVID-19 and hair loss, healthcare professionals can provide appropriate guidance and support to affected individuals.

‘New study reveals COVID-19 can cause hair loss. Telogen effluvium (TE) affects recovered patients, leading to diffuse shedding. Understanding this helps educate and support those experiencing post-COVID hair loss. #COVID19 #HairLoss #TelogenEffluvium’

In conclusion, this study highlights the presence of hair loss as a sequela of COVID-19 infection. The findings emphasize the need to address the psychological and physical effects of telogen effluvium in post-COVID-19 patients. By raising awareness and offering appropriate management strategies, healthcare providers can help individuals navigate the challenges associated with hair loss and improve their overall well-being.

Reference:

Comparing the Effects of Zinc Sulfate, Calcium Pantothenate, Their Combination and Minoxidil Solution Regimens on Controlling Hair Loss in Women: A Randomized Controlled Trial - (https:pubmed.ncbi.nlm.nih.gov/28616431/)

Source: Medindia

Cite this Article ⇣⇡

Please use one of the following formats to cite this article in your essay, paper or report:

APA
Dr. Trupti Shirole. (2023, June 03). Telogen Effluvium: Understanding Hair Loss as a Sequela of COVID-19. Medindia. Retrieved on Nov 23, 2024 from https://www.medindia.net/news/healthwatch/telogen-effluvium-understanding-hair-loss-as-a-sequela-of-covid-19-212077-1.htm.
MLA
Dr. Trupti Shirole. "Telogen Effluvium: Understanding Hair Loss as a Sequela of COVID-19". Medindia. Nov 23, 2024. <https://www.medindia.net/news/healthwatch/telogen-effluvium-understanding-hair-loss-as-a-sequela-of-covid-19-212077-1.htm>.
Chicago
Dr. Trupti Shirole. "Telogen Effluvium: Understanding Hair Loss as a Sequela of COVID-19". Medindia. https://www.medindia.net/news/healthwatch/telogen-effluvium-understanding-hair-loss-as-a-sequela-of-covid-19-212077-1.htm. (accessed Nov 23, 2024).
Harvard
Dr. Trupti Shirole. 2023. Telogen Effluvium: Understanding Hair Loss as a Sequela of COVID-19. Medindia, viewed Nov 23, 2024, https://www.medindia.net/news/healthwatch/telogen-effluvium-understanding-hair-loss-as-a-sequela-of-covid-19-212077-1.htm.